Generics/Substitute
-
Rs. 852.50
Description
| Medicine | |
| Alchohol Interaction | Interaction with alcohol is unknown. Please consult your doctor. |
| Pregnancy Interaction | Unknown. Human and animal studies are not available. Please consult your doctor. |
| Lactation Interaction | Emvoid 125 mg/80 mg Capsule is probably unsafe to use during lactation. \nLimited human data suggest that the drug could represent a significant risk to the baby. |
| Common Side Effect | Constipation, Indigestion, Headache, Tiredness, Loss of appetite, Hiccup, Increased liver enzymes. |
| How to Use | Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Emvoid 125 mg/80 mg Capsule may be taken with or without food, but it is better to take it at a fixed time. |
| Driving | Emvoid 125 mg/80 mg Capsule may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive. |
| Kidney | Emvoid 125 mg/80 mg Capsule is safe to use in patients with kidney disease. No dose adjustment of Emvoid 125 mg/80 mg Capsule is recommended. |
| Liver | Emvoid 125 mg/80 mg Capsule is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Emvoid 125 mg/80 mg Capsule may not be needed in these patients. Please consult your doctor. |
| Mechanism of action | Emvoid 125 mg/80 mg Capsule is a combination of two different doses of Aprepitant. It works by blocking the action of a chemical messenger in the brain that may cause nausea and vomiting during treatment with anti-cancer medicines. |